Crown Princess Mette-Marit of Norway has undergone a lung transplant in Oslo, with a team of British specialists providing oversight of her post-operative care. The procedure, performed at Oslo University Hospital, marks a significant stage in the princess’s long-running battle with idiopathic pulmonary fibrosis, a chronic lung disease that has no known cure.
Palace officials confirmed the surgery on Monday, stating that the 48-year-old royal had been on a waiting list for a donor organ for several months. The operation, which lasted over eight hours, was carried out by a Norwegian surgical team. However, the palace noted that the immediate post-transplant management is being directed by experts from the Royal Brompton and Harefield Hospitals in London, institutions recognised for their world-leading work in lung transplantation and fibrosis treatment.
The involvement of British clinicians underscores the close medical ties between the two countries and the limited pool of expertise for such complex cases. Norway, a nation of 5.5 million people, conducts around 20 lung transplants annually. The Royal Brompton and Harefield has performed over 2,000 such procedures.
Crown Princess Mette-Marit has endured a decade of illness, diagnosed with pulmonary fibrosis in 2018 after years of unexplained fatigue and breathlessness. The disease, which causes progressive scarring of the lungs, forced her to withdraw from numerous public engagements. Last year, she stepped down from several patronages, citing her health. In a rare televised interview in 2022, she spoke of the “uncertainty” of her condition and the need for “patience in the face of what cannot be controlled.”
Norwegian medical experts have warned that a lung transplant carries considerable risks, including rejection and infection. Recipients typically require lifelong immunosuppressive drugs and frequent hospital monitoring. The first month after surgery is regarded as the most critical. Palace officials said the princess would remain in hospital for several weeks and provided no date for her return to royal duties.
The transplant has drawn international attention, reflecting the public affection for Mette-Marit and her role as consort to Crown Prince Haakon, the heir to the throne. The couple married in 2001, and she has gradually taken on a more prominent diplomatic role, with a focus on mental health, HIV/AIDS, and refugees. Her illness has been a recurring backdrop to her public life, often prompting debate about the balance between royal duty and personal health.
Norwegian Prime Minister Jonas Gahr Store issued a statement wishing the princess a full recovery and praising the medical teams involved. British officials have also expressed support. The British ambassador to Norway, Richard Wood, said the UK was “proud to support our Norwegian friends in this critical hour.”
The transplant comes at a time of broader strain on Norway’s healthcare system, with waiting lists for many procedures lengthening. The hospital declined to comment on whether the donor was Norwegian or from elsewhere, citing patient confidentiality. In Norway, organ donation is based on an opt-out system, and donor rates are moderate by European standards.
For the crown princess, the procedure offers a chance for renewed vitality, but doctors caution that recovery is a marathon, not a sprint. The palace has asked for privacy as she and her family navigate this next phase. Her husband and three children have been regular visitors to the hospital. Official engagements for the royal family are expected to be curtailed until her condition stabilises.
